NASDAQ:FBLG Stock Quote

FibroBiologics, Inc. is a biotechnology company focused on developing innovative cell therapies and regenerative medicine solutions, primarily utilizing fibroblast cells

The company aims to address various medical conditions by harnessing the unique properties of these cells, which play a crucial role in wound healing and tissue repair. Through advanced research and clinical development, FibroBiologics seeks to create effective treatments for conditions such as chronic wounds, orthopedic injuries, and other degenerative diseases, ultimately improving the quality of life for patients through its cutting-edge therapeutic approaches.